327 Shares in Axon Enterprise, Inc $AXON Purchased by TABR Capital Management LLC

TABR Capital Management LLC acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON) during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 327 shares of the biotechnology company’s stock, valued at approximately $271,000. Axon Enterprise accounts for approximately 0.2% of TABR Capital Management LLC’s investment portfolio, making the stock its 26th biggest holding.

A number of other institutional investors and hedge funds have also made changes to their positions in the business. Jennison Associates LLC boosted its position in shares of Axon Enterprise by 23,203.7% in the 1st quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company’s stock worth $322,961,000 after purchasing an additional 611,418 shares in the last quarter. Nuveen LLC purchased a new position in Axon Enterprise during the first quarter valued at $264,796,000. Westfield Capital Management Co. LP raised its stake in Axon Enterprise by 29.8% during the first quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company’s stock valued at $487,977,000 after buying an additional 212,931 shares during the last quarter. Vanguard Group Inc. boosted its holdings in Axon Enterprise by 2.2% in the first quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company’s stock worth $4,540,005,000 after acquiring an additional 185,571 shares in the last quarter. Finally, Axiom Investors LLC DE purchased a new stake in shares of Axon Enterprise in the first quarter worth $93,088,000. Institutional investors own 79.08% of the company’s stock.

Insider Transactions at Axon Enterprise

In related news, President Joshua Isner sold 15,919 shares of Axon Enterprise stock in a transaction on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the completion of the sale, the president owned 238,379 shares of the company’s stock, valued at $177,892,712.54. The trade was a 6.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CEO Patrick W. Smith sold 10,000 shares of the company’s stock in a transaction on Monday, August 11th. The shares were sold at an average price of $831.29, for a total value of $8,312,900.00. Following the sale, the chief executive officer owned 3,053,982 shares of the company’s stock, valued at approximately $2,538,744,696.78. This trade represents a 0.33% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 49,932 shares of company stock worth $37,978,216. Company insiders own 5.70% of the company’s stock.

Axon Enterprise Stock Up 0.2%

AXON opened at $717.64 on Wednesday. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. The firm has a 50 day moving average price of $757.83 and a 200-day moving average price of $704.96. Axon Enterprise, Inc has a twelve month low of $395.37 and a twelve month high of $885.91. The stock has a market capitalization of $56.34 billion, a price-to-earnings ratio of 177.20, a PEG ratio of 27.80 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company had revenue of $668.54 million for the quarter, compared to the consensus estimate of $641.77 million. During the same quarter in the prior year, the firm earned $1.20 earnings per share. The firm’s revenue for the quarter was up 32.6% compared to the same quarter last year. Axon Enterprise has set its FY 2025 guidance at EPS. Equities research analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current year.

Analyst Upgrades and Downgrades

AXON has been the subject of several analyst reports. Bank of America raised their price target on Axon Enterprise from $895.00 to $1,000.00 and gave the company a “buy” rating in a report on Wednesday, August 6th. Craig Hallum raised shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price objective on the stock in a research report on Tuesday, August 5th. Raymond James Financial restated an “outperform” rating and set a $855.00 price objective (up from $645.00) on shares of Axon Enterprise in a research note on Tuesday, August 5th. Wolfe Research began coverage on shares of Axon Enterprise in a research note on Monday, July 7th. They issued an “outperform” rating on the stock. Finally, Northland Securities set a $800.00 price target on shares of Axon Enterprise in a report on Tuesday, August 5th. Fourteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $841.64.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.